It has been shown that activation of PPARγ by pioglitazone can attenuate cardiac fibrosis and partly ameliorate cardiac remodeling and function by suppressing activity of RAS, in a rat model of diabetes (42). The gene discussed is PPARG; the disease is diabetes mellitus.